Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating tuberculostearic acid in tuberculosis patients.

Friederike Traunmüller1, Markus Alexander Zeitlinger, Brigitte Stoiser

  • 1Department of Internal Medicine, Division of Infectious Diseases, University Hospital of Vienna, Austria. f.traunmueller@gmx.net

Scandinavian Journal of Infectious Diseases
|January 16, 2004
PubMed
Summary

Plasma tuberculostearic acid (TBSA) levels are significantly higher in active tuberculosis patients. This mycobacterial marker shows high sensitivity and specificity, suggesting TBSA as a valuable complementary diagnostic tool for tuberculosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Antimicrobial agents and chemotherapy·2026
Same author

Multicenter Genomic Analysis of Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> in Austrian Community Hospitals Reveals Limited Carbapenemase Prevalence and Absence of Interhospital Clonal Spread.

Antibiotics (Basel, Switzerland)·2026
Same author

Ergosterol-depleted clinical isolates of <i>Nakaseomyces glabratus</i> can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model.

mBio·2026
Same author

Current state and potential of hospitals for automated healthcare-associated infection surveillance: data from 24 European countries, 2022 to 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Position statement: integrating planetary health into infection prevention and control in healthcare settings-towards a balanced and evidence-based approach.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Cystic echinococcosis (hydatid disease): current insights into epidemiology, diagnosis, therapy, and prophylaxis.

British medical bulletin·2026

Area of Science:

  • Biochemistry
  • Microbiology
  • Clinical Diagnostics

Background:

  • Tuberculostearic acid (TBSA) is a unique lipid component of mycobacterial cell walls.
  • Accurate and early diagnosis of tuberculosis (TB) remains a global health challenge.
  • Novel biomarkers are needed to improve TB detection rates.

Purpose of the Study:

  • To quantify plasma TBSA concentrations in patients with active tuberculosis.
  • To compare TBSA levels between active TB, other inflammatory conditions, and healthy individuals.
  • To evaluate the diagnostic performance of plasma TBSA for active TB.

Main Methods:

  • Plasma samples were analyzed for TBSA using a highly sensitive high-performance liquid chromatography (HPLC) method.
  • TBSA concentrations were measured in 125 active TB patients, 116 patients with inflammatory conditions, and 102 healthy controls.

Related Experiment Videos

  • Diagnostic accuracy metrics including sensitivity, specificity, and predictive values were calculated.
  • Main Results:

    • Plasma TBSA concentrations were significantly elevated in active TB patients (median 20 nmol/l) compared to non-TB inflammatory conditions (median 0.1 nmol/l) and healthy controls (median 0 nmol/l) (p < 0.001).
    • The assay demonstrated high diagnostic performance for active TB: sensitivity 95.2%, specificity 87.9%, positive predictive value 89.5%, and negative predictive value 94.4%.

    Conclusions:

    • Plasma TBSA is a promising biomarker for active tuberculosis.
    • Assay of plasma TBSA can serve as a valuable complementary diagnostic tool for TB.
    • Further research may validate TBSA for widespread clinical use in TB diagnostics.